The invention relates to the use of arsenic compounds to treat a variety of leukemia,
lymphoma and solid tumors. Further, the arsenic compounds may be used in combination
with other therapeutic agents, such as a retinoid. The invention also provides
a process for producing arsenic trioxide formulations.
